About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Open-label Extension Study Of RN624 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00399490

Open-label Extension Study Of RN624

Study RN624-CL007 is planned to be an open-label protocol to enroll subjects who have previously participated in Study No. RN624-CL006. In this study, subjects will receive RN624 on an open-label basi...

Lead sponsor: Pfizer•36 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pfizer

Age

40 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Enrolled in Study RN624-CL006

Exclusion Criteria

•The occurrence of any adverse event or condition during the controlled studies that, in the opinion of the Investigator, should exclude the subject from participating in the open-label extension
•Pregnant or lactating female subjects or subjects who do not agree to use an appropriate form of birth control throughout the study and for 3 months after completing the study

Related studies

RECRUITINGPhase 3

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

NCT07226258 · Osteoarthritis Knee Pain

RECRUITINGPhase 2

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

NCT07486960 · Psoriatic Arthritis

An Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis

NCT07627542 · Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and more

RECRUITINGPhase 2

Desloratadine as Adjunct Therapy for Rheumatoid Arthritis

NCT07632872 · Rheumatoid Arthritis (RA), Rheumatoid Arthritis

FDG PET/MRI Imaging of Patellofemoral Joint Osteoarthritis

NCT07625150 · Patellofemoral Osteoarthritis, Knee Osteoarthritis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 2, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment287

Start dateSep 2006

Last updatedFeb 2, 2021

Condition

Osteoarthritis OA Knee Pain Arthritis

Locations shown

BrookWood Internal Medicine

Birmingham, Alabama

Radiant Research

Birmingham, Alabama

Arizona Research Center, LLC

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions